Results 121 to 130 of about 65,325 (216)

Recovery of Antibody Immunity After a Resurgence of Respiratory Syncytial Virus Infections. [PDF]

J Infect Dis
Reicherz F, Viñeta Paramo M, Bone JN, Lavoie A, Li S, Golding L, Jassem A, Watts A, Abu-Raya B, Lavoie PM.   +9 more
europepmc   +1 more source

Early risk identification for recurrent wheezing in children with respiratory syncytial virus infections. [PDF]

Am J Transl Res
Wang Y, Shi Y, Wang L.
europepmc   +1 more source

Respiratory syncytial virus infections - recent developments providing promising new tools for disease prevention. [PDF]

Euro Surveill, 2023
Broberg EK, Nohynek H.
europepmc   +1 more source

Optimizing the sensitivity of detection of respiratory syncytial virus infections in longitudinal studies using the combination of weekly sample testing and biannual serology. [PDF]

Am J Epidemiol
Conrey SC, Payne DC, Leon MD, Epperson M, Coughlin MM, Burrell AR, Mattison CP, Burke RM, Baker JM, Thornburg NJ, McMorrow ML, Staat MA, Morrow AL.   +12 more
europepmc   +1 more source

Epidemiology of moderate-to-severe respiratory syncytial virus infections in children in subtropical Okinawa, Japan: a 4-year retrospective study. [PDF]

Trop Med Health
Fukuoka-Araki K, Araki K, Fukuoka H, Cho Y, Matayoshi K, Makiya T, Kinjo S, Yamashiro T.   +7 more
europepmc   +1 more source

Genetic and Epidemiological Insights Into Respiratory Syncytial Virus Infections: A Comparative Study of Hospitalized Versus Community Cases in Portugal (2021-2023). [PDF]

Influenza Other Respir Viruses
Lança M, Gaio V, Rodrigues AP, Henriques C, Gomes L, Dias D, de Jesus Chasqueira M, Guiomar R, Melo A.   +8 more
europepmc   +1 more source

Estimated Incidence of All-Cause Respiratory Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Finland between 2011 and 2019: A Retrospective Database Study. [PDF]

J Epidemiol Glob Health
Bruyndonckx R, Polkowska-Kramek A, Liang C, Kosunen M, Hätinen OP, Esnaola M, Casas M, Peerawaranun P, Ewnetu WB, Gessner BD, Begier E.   +10 more
europepmc   +1 more source

Clinical progression parameters associated with SARS-CoV-2, influenza, and respiratory syncytial virus infections in a large US integrated healthcare population. [PDF]

PLoS Comput Biol
Parker NT, Hong V, Davis GS, Pomichowski M, Reyes IA, Xie F, Mueller NF, Rodriguez-Barraquer I, Tartof SY, Lewnard JA.   +9 more
europepmc   +1 more source

Six-year epidemiological dynamics of human respiratory syncytial virus infections in children in central China (2019-2024): pandemic suppression, 2023 resurgence, and immune debt effect. [PDF]

Front Cell Infect Microbiol
Xia Z, Li X, Shen A, Mokrousov I, Guo P, Zhang Y.   +5 more
europepmc   +1 more source

Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections. [PDF]

Hum Vaccin Immunother, 2023
Weil-Olivier C, Salisbury D, Navarro-Alonso JA, Tzialla C, Zhang Y, Esposito S, Midulla F, Tenenbaum T.   +7 more
europepmc   +1 more source